These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8254465)

  • 1. Association of immune activation with intravenous heroin use and methadone treatment in HIV-1 seropositive and seronegative subjects.
    Di Franco MJ; Marlink R; Hunter DJ; Tosteson T; Mayer K; Essex M
    J Acquir Immune Defic Syndr (1988); 1993 Dec; 6(12):1297-300. PubMed ID: 8254465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychological impairment among asymptomatic HIV-positive former intravenous drug users.
    Rodríguez Salgado D; Rodríguez Alvarez M; Seoane Pesqueira G
    Cogn Behav Neurol; 2006 Jun; 19(2):95-104. PubMed ID: 16783132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users.
    Graham NM; Nelson KE; Solomon L; Bonds M; Rizzo RT; Scavotto J; Astemborski J; Vlahov D
    JAMA; 1992 Jan; 267(3):369-73. PubMed ID: 1727959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum concentrations of circulating endogenous granulocyte-macrophage colony-stimulating factor in HIV-1-seropositive injecting drug users.
    Herold M; Meise U; Günther V; Rössler H; Zangerle R
    Presse Med; 1994 Dec; 23(40):1854-8. PubMed ID: 7899316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune function and anti-HTLV-I/II status in anti-HIV-1-negative intravenous drug users receiving methadone.
    Klimas NG; Blaney NT; Morgan RO; Chitwood D; Milles K; Lee H; Fletcher MA
    Am J Med; 1991 Feb; 90(2):163-70. PubMed ID: 1671730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated serum levels of neopterin but not beta 2-microglobulin in HIV-1-seronegative injecting drug users.
    Strickler HD; Blanchard JF; Vlahov D; Taylor E; Muñoz A; Nelson KE; Margolick JB
    AIDS; 1993 Mar; 7(3):361-7. PubMed ID: 8471199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune serum markers and CD4 cell counts in HIV-infected intravenous drug users.
    Chaisson RE; Taylor E; Margolick JB; Muñoz A; Solomon L; Cohn S; Nelson KE; Vlahov D
    J Acquir Immune Defic Syndr (1988); 1992; 5(5):456-60. PubMed ID: 1348535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of methadone on immunological parameters among HIV-positive and HIV-negative drug users.
    Carballo-Diéguez A; Sahs J; Goetz R; el Sadr W; Sorell S; Gorman J
    Am J Drug Alcohol Abuse; 1994 Aug; 20(3):317-29. PubMed ID: 7977217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum neopterin level predicts HIV-related mortality but not progression to AIDS or development of neurological disease in gay men and parenteral drug users.
    Sacktor N; Liu X; Popescu M; Marder K; Stern Y; Mayeux R
    Arch Neurol; 1995 Jul; 52(7):676-9. PubMed ID: 7619023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral risk factors of human immunodeficiency virus infection among intravenous drug users and implications for preventive interventions.
    Nemoto T; Brown LS; Foster K; Chu A
    AIDS Educ Prev; 1990; 2(2):116-26. PubMed ID: 2393617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Close relationships between neopterin and beta-2-microglobulin levels in intravenous drug abusers.
    Lin RY; Nygren E; Valinsky J; Lorenzana FG; Ralph H
    Int Arch Allergy Appl Immunol; 1990; 91(4):389-93. PubMed ID: 1976599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Levels of neopterin in serum of narcotics abusers infected with human immunodeficiency virus (HIV)].
    Rogowska-Szadkowska D; Borzuchowska A; Prokopowicz D; Grzeszczuk A; Chodynicka B; Rogowski F; Kramarz P
    Pol Arch Med Wewn; 1994 May; 91(5):363-6. PubMed ID: 8084813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevalence of HIV-1 infection in intravenous drug dependent patients 1986 to 1989 in Vienna].
    Loimer N; Presslich O; Hollerer E; Werner E; Pakesch G; Pfersmann V; Schmid-Siegel B; Aschauer G
    Wien Klin Wochenschr; 1990 Feb; 102(4):106-10. PubMed ID: 2316224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of zidovudine treatment on serum neopterin and beta 2-microglobulin levels in mildly symptomatic, HIV type 1 seropositive individuals.
    Bass HZ; Hardy WD; Mitsuyasu RT; Taylor JM; Wang YX; Fischl MA; Spector SA; Richman DD; Fahey JL
    J Acquir Immune Defic Syndr (1988); 1992; 5(3):215-21. PubMed ID: 1346807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between neopterin and beta-2-microglobulin levels and HIV status in Romanian orphanage children.
    Zaknun D; DiFranco M; Oswald HP; Zaknun J; Mayersbach P; Vuja E; Wachter H; Fuchs D
    Wien Klin Wochenschr; 1993; 105(10):284-8. PubMed ID: 8517058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in T-lymphocyte subsets in intravenous drug users with HIV-1 infection.
    Margolick JB; Muñoz A; Vlahov D; Solomon L; Astemborski J; Cohn S; Nelson KE
    JAMA; 1992 Mar; 267(12):1631-6. PubMed ID: 1347321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [HIV prevention in HIV-positive drug addicts. A methadone-supported model].
    Oertle D; Edelmann R; Ostewalder J; Vernazza PL; Galeazzi RL
    Schweiz Med Wochenschr; 1993 Dec; 123(48):2284-92. PubMed ID: 8272803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy.
    Selwyn PA; Sckell BM; Alcabes P; Friedland GH; Klein RS; Schoenbaum EE
    JAMA; 1992 Jul 22-29; 268(4):504-9. PubMed ID: 1619742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of serum and urine neopterin concentrations in patients with HIV-1 infection.
    Fuchs D; Jaeger H; Popescu M; Reibnegger G; Werner ER; Kaboth W; Wachter H
    Clin Chim Acta; 1990 Feb; 187(2):125-30. PubMed ID: 2317931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Why I am not infected with HIV": implications for long-term HIV risk reduction and HIV vaccine trials.
    Des Jarlais DC; Vanichseni S; Marmor M; Buavirat A; Titus S; Raktham S; Friedmann P; Kitayaporn D; Wolfe H; Friedman SR; Mastro TD
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Dec; 16(5):393-9. PubMed ID: 9420319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.